Plasma proteomics identifies a ‘chemokine storm’ in idiopathic multicentric Castleman disease-Reference-Cited by-同舟云学术

Plasma proteomics identifies a ‘chemokine storm’ in idiopathic multicentric Castleman disease

Published:2018-05-16 Issue:7 Volume:93 Page:902-912
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Pierson Sheila K.¹,Stonestrom Aaron J.²,Shilling Dustin¹,Ruth Jason³,Nabel Christopher S.³,Singh Amrit⁴,Ren Yue¹,Stone Katie⁵,Li Hongzhe¹,van Rhee Frits⁵,Fajgenbaum David C.¹^ORCID

Affiliation:

1. University of Pennsylvania; Philadelphia Pennsylvania

2. Hospital of the University of Pennsylvania; Philadelphia Pennsylvania

3. Castleman Disease Collaborative Network; Boston Massachusetts

4. University of British Columbia; Vancouver Canada

5. University of Arkansas for Medical Sciences; Little Rock Arkansas

Funder

Castleman Disease Collaborative Network

Publisher

Wiley

Subject

Hematology

Reference68 articles.

1. Use of a claims database to characterize and estimate the incidence rate for Castleman disease;Munshi;Leuk Lymphoma.,2015

2. The clinical spectrum of Castleman's disease;Dispenzieri;Am J Hematol.,2012

3. Clinical dissection of multicentric Castleman disease;Shin;Leuk Lymphoma.,2011

4. Clinical and morphological features of different types of Castleman's disease];Melikyan;Ter Arkh.,2015

5. International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease;Fajgenbaum;Blood.,2017

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spatial and Single Cell Mapping of Castleman Disease Reveals Key Stromal Cell Types and Cytokine Pathways;2024-09-11

2. A hypothesis on treatment strategy of severe multicentric Castleman disease with continuous renal replacement therapy;Journal of Cellular and Molecular Medicine;2024-09

3. scRNA‐seq reveals the landscape of immune repertoire of PBMNCs in iMCD;Oncogene;2024-08-15

4. Successful treatment of relapsed idiopathic multicentric Castleman disease–idiopathic plasmacytic lymphadenopathy with orelabrutinib monotherapy: A case report;British Journal of Haematology;2024-06-10

5. Overview of Research Status in Castleman Disease;Clinical Lymphoma Myeloma and Leukemia;2024-06